Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2.
Joanne DohertyVinay MandatiMaria A González RodriguezScott TroutmanAlyssa ShepardDavid HarbaughRachel BrodyDouglas C MillerMichael S KaretaJoseph L KissilPublished in: Neuro-oncology advances (2022)
-deficient schwannomas.
Keyphrases